Indoor Harvest, Corp. (OTCQB:INQD) is a developer of personalized cannabis medicines, and a provider of advanced cultivation technology, methods and processes. The Company provides the cannabis industry production platforms for building integrated agriculture (BIA) production. Our patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale.
American Green, Inc (OTC: ERBB) became, in 2009, America’s second publicly-traded company in the cannabis industry. American Green now, with its more than 50,000 individual certified shareholders, is one of the largest (in shareholder count) in the cannabis sector. American Green’s mission is to lead the cannabis and premium CBD industry. Leveraging our team of professionals in cultivation management, manufacturing, extraction, wholesale, retail, and community outreach, we strive to develop sustainable initiatives in the cannabis-adjacent and CBD industries, laser-focused on adding company and shareholder value.
CBD of Denver, Inc. (OTC: CBDD) is participating in the development of innovative CBD products and related social networking. The Company’s networking website can be accessed at: www.cbdsocialnetwork.com. The site will be connecting CBD enthusiasts from around the world.
CV Sciences, Inc. (OTC: CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a pharmaceutical division focused on developing and commercializing CBD-based novel therapeutics. The Company’s PlusCBD Oil consumer products are sold at more than 5,500 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD in the natural product retail market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences’ state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm purity and content to meet strict company quality standards. With a commitment to science, PlusCBD Oil’s benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD Oil was the first hemp-derived CBD supplement brand to invest in the scientific evidence necessary to achieve self-affirmed Generally Recognized as Safe (GRAS) status. The Company’s pharmaceutical division focuses on developing and commercializing proprietary prescription drugs utilizing cannabidiol (CBD) as the active pharmaceutical ingredient. CV SciencesÃ¢ÂÂ initial drug candidate (CVSI-007) combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at greater than $2 billion.
Terra Tech Corp. (OTC: TRTC), which recently merged with OneQor Pharmaceutical, is a holding company with a portfolio of investments focused on cannabis agricultural assets in the THC market and the research, development and commercialization of cannabinoid-based products. Backed by innovative science and best-in-class manufacturing, the company’s mission is to deliver top-tier cannabis and cannabinoid-based products across the wide range of emerging consumer markets for plant-based health products, including CBD, pharmaceuticals and consumer brands.